EGFR and metabolic dysfunction-associated steatohepatitis: Although the increased phospho-EGFR expression in the MUP-uPA background liver was attenuated by HNK treatment, HNK treatment clearly suppressed EGFR and FKBP5 protein expressions in the background NASH liver.